Bain Capital Specialty Finance Inc.
BCSF | NYSE
$11.21
+$0.12 (+1.08%)
At close: Sep 21, 2026, 4:00 PM ET
$11.26
+$0.05 (+0.45%)
Pre-market:
Sep 22, 2026, 7:35 AM ET
Company Profile
Bain Capital Specialty Finance, Inc. functions as a business development company (BDC) whose primary focus is providing direct debt solutions to companies in the middle market segment. The fund's investment mandate is broad, covering a spectrum of debt instruments. This includes various forms of secured senior debt, such as first-lien, stretch senior, and second-lien facilities. It also invests in hybrid financing structures like unitranche loans, as well as subordinated or junior capital, which encompasses mezzanine debt and other junior securities. Furthermore, the firm engages in the secondary acquisition of assets or portfolios, primarily comprising corporate debt from middle-market businesses. Generally, Bain Capital Specialty Finance targets companies that generate annual earnings before interest, taxes, depreciation, and amortization (EBITDA) between $10 million and $150 million.
Key Executives
| Name | Position |
|---|---|
| Michael Alexander Ewald | Chief Executive Officer |
| Amit Joshi | Treasurer & CFO |
| Caroline Willis Hooper | Chief Compliance Officer |
| James Goldman | Chief Compliance Officer |
| Katherine Schneider | Secretary |
| Michael Boyle | President & Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 10, 2026 | 8-K | Current Report |
| Aug 10, 2026 | 10-Q | Quarterly Report |
| Jul 31, 2026 | 8-K | Current Report |
| Jul 23, 2026 | 8-K | Current Report |
| May 22, 2026 | 8-K | Current Report |
| May 12, 2026 | 8-K | Current Report |
| May 11, 2026 | 10-Q | Quarterly Report |
| Apr 29, 2026 | 8-K | Current Report |
| Apr 27, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Apr 20, 2026 | DEF 14A | Filing |
Bain Capital Specialty Finance Inc.
| Country | United States |
| IPO Date | Nov 14, 2018 |
| Industry | Asset Management |
| Sector | Financial Services |
| Employees | 0 |
| CEO | Michael Alexander Ewald |
Contact Details
200 Clarendon Street Boston,
Massachusetts 02116 United States
Stock Details
| Ticker Symbol | BCSF |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001655050 |
| CUSIP Number | 05684B107 |
| ISIN Number | US05684B1070 |
| SIC Code |
Add to Watchlist
Select watchlists to add or remove BCSF